Peio Errarte
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 15
- Peptidase Inhibition and Analysis 12
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 3
-
- Renal cell carcinoma treatment 8
- Co-authors
- Gorka Larrinaga (19 shared papers)José I. López (17 shared papers)Maider Beitia (11 shared papers)J.C. Angulo (7 shared papers)Rafael Pulido (6 shared papers)Carmen Etxezarraga (6 shared papers)Lorena Blanco (6 shared papers)Itxaro Pérez (8 shared papers)
- Journals
- Cancers (5 papers)International Journal of Medical Sciences (3 papers)PLoS ONE (3 papers)Human Pathology (2 papers)Journal of Investigative Medicine (1 paper)
- Partner nations
- SpainNorwayUnited Kingdom
In The Last Decade
Peio Errarte
21 papers receiving 486 citations
Peers
Comparison fields: 5 of 53
- Oncology 266
- Cancer Research 89
- Pulmonary and Respiratory Medicine 115
- Immunology 44
- Molecular Biology 147
Countries citing papers authored by Peio Errarte
This map shows the geographic impact of Peio Errarte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peio Errarte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peio Errarte more than expected).
Fields of papers citing papers by Peio Errarte
This network shows the impact of papers produced by Peio Errarte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peio Errarte. The network helps show where Peio Errarte may publish in the future.
Co-authors
The 25 scholars most cited alongside Peio Errarte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 53 | |
| 2 | 2019 | 53 | |
| 3 | 2016 | 51 | |
| 4 | 2016 | 51 | |
| 5 | 2021 | 35 | |
| 6 | 2017 | 35 | |
| 7 | 2020 | 33 | |
| 8 | 2015 | 31 | |
| 9 | 2020 | 26 | |
| 10 | 2015 | 24 | |
| 11 | 2014 | 23 | |
| 12 | 2019 | 11 | |
| 13 | 2013 | 11 | |
| 14 | 2013 | 10 | |
| 15 | 2019 | 10 | |
| 16 | 2023 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2015 | 6 | |
| 19 | 2024 | 4 | |
| 20 | 2020 | 2 |
About Peio Errarte
Peio Errarte is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 486 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (12 papers), Renal cell carcinoma treatment (8 papers), Pancreatic and Hepatic Oncology Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Renin-Angiotensin System Studies (3 papers), Hormonal Regulation and Hypertension (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (266 citations), Cancer Research (89 citations), Pulmonary and Respiratory Medicine (115 citations), Immunology (44 citations) and Molecular Biology (147 citations). Peio Errarte has collaborated with scholars based in Spain, Norway and United Kingdom. Frequent co-authors include Gorka Larrinaga, José I. López, Maider Beitia, J.C. Angulo, Rafael Pulido, Carmen Etxezarraga, Lorena Blanco, Itxaro Pérez, Begoña Sanz and Caroline E. Nunes‐Xavier. Their work appears in journals such as Cancers, International Journal of Medical Sciences, PLoS ONE, Human Pathology and Journal of Investigative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.